Non-Invasive Prenatal Testing Market - Forecast(2024 - 2030)

Report Code: HCR 83007 Report Format: PDF + Excel

Non-Invasive Prenatal Testing Market Overview

Non-Invasive Prenatal Testing Market size is estimated to reach $9.8 billion by 2026, growing at a CAGR of 13.1% during the forecast period 2021-2026. Prenatal testing is a procedure of determining the risk of whether the fetus of the mother will be born with any genetic abnormalities. This method also analyzes fragments of Deoxyribonucleic acid (DNA) that are circulating in pregnant blood. This non-invasive prenatal testing has grown out of a desire to avoid direct contact with the fetus. The rise in the adoption of cell-free DNA screening for predicting the risk of genetic conditions, growing adoption of ultrasound detection methods in hospitals, increase in the risk of chromosomal abnormalities with rising maternal age, and growing demand for chorionic villus sampling and amniocentesis in diagnostic laboratories are the factors that are set to drive the growth of the Non-Invasive Prenatal Testing Market for the period 2021-2026.

Report Coverage

The report: “Non-Invasive Prenatal Testing Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Non-Invasive Prenatal Testing Market.
By Product Type: Consumables, Assay Kits and Reagents, Disposables, Instruments, Microarrays, Ultrasound Devices, and Others.
By Method: Ultrasound Detection, Biochemical Screening Test, Cell-free DNA Screening in Maternal Plasma Test, and Fetal Cell in Maternal Blood Test.
By Application: Trisomy, Microdeletion Syndrome, and Others.
By End User: Diagnostic Laboratories, Hospitals, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Non-Invasive Prenatal Testing Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing demand for chorionic villus sampling and amniocentesis in diagnostic laboratories.
  • The rise in the adoption of cell-free DNA screening for predicting the risk of genetic conditions is driving the Cell-free DNA Screening in Maternal Plasma Test segment. However, the high cost of non-invasive prenatal testing is one of the major factors that is said to reduce the growth of the Non-Invasive Prenatal Testing Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Non-Invasive Prenatal Testing Market report.

Non-Invasive Prenatal Testing Market Size, By Method, 2020-2026 (USD Million)
Non-Invasive Prenatal Testing Market
For More Details on This Report - Request for Sample

Non-Invasive Prenatal Testing Market Segment Analysis-By Method

The Non-Invasive Prenatal Testing Market based on the Method can be further segmented into Ultrasound Detection, Biochemical Screening Test, Cell-free DNA Screening in Maternal Plasma Test, and Fetal Cell in Maternal Blood Test. The Cell-free DNA Screening in Maternal Plasma Test segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 14.7% over the period 2021-2026. 

This growth is owing to the factors such as the rise in the company initiatives to develop new products and growing research studies to further advance the use of tests offered. The rise in the adoption of Cell-free DNA Screening for predicting the risk of genetic conditions is driving the growth of the Non-Invasive Prenatal Testing Market. The Ultrasound Detection segment held the second largest share in 2020 owing to the factors such as the growing demand for non-invasive and safe methods for both mother and unborn baby and the rise in the adoption of ultrasound detection as complementary to Cell-free DNA screening.

Non-Invasive Prenatal Testing Market Segment Analysis-By End User

The Non-Invasive Prenatal Testing Market based on the End User can be further segmented into Diagnostic Laboratories, Hospitals, and Others. The Diagnostic Laboratories segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 14.3% over the period 2021-2026. This growth is owing to the factors such as increase in the initiatives by diagnostic laboratories to provide effective prenatal tests and growing incidences of chromosomal abnormalities.

The growing demand for chorionic villus sampling and amniocentesis in diagnostic laboratories is driving the growth of the Non-Invasive Prenatal Testing Market. The Hospitals segment held the second largest share in 2020 owing to the factors such as the growing adoption of ultrasound detection methods in hospitals in developed nations and the increase in the investment by the key players to launch advanced equipment in hospitals.

Non-Invasive Prenatal Testing Market Segment Analysis-By Geography

North America held the largest share with 31% of the overall market in 2020. The growth in this segment is owing to the factors such as rise in the demand for chorionic villus sampling and amniocentesis in diagnostic laboratories and increase in the risk of chromosomal abnormalities with rising maternal age. The rise in the adoption of ultrasound detection methods in developed nations is driving the growth of the Non-Invasive Prenatal Testing Market. 

Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as the growing adoption of Cell-free DNA Screening for predicting the risk of genetic conditions and the increase in the initiatives by governments and diagnostic laboratories to provide effective prenatal tests.

Non-Invasive Prenatal Testing Market Drivers

Rise in the Adoption of Cell-free DNA Screening

The Cell-free DNA screening in maternal plasma tests has a lower false rate and a higher detection rate than other screening methods. Cell-free DNA screening test has the ability to determine whether a mother has a chance of having a fetus with trisomy syndrome. The rise in the adoption of Cell-free DNA Screening in predicting the risk of genetic conditions and growing research studies are further propelling the growth of the Non-Invasive Prenatal Testing Market.

Increase in the Risk of Chromosomal Abnormalities with Rising Maternal Age.

The maternal age has been shifted owing to various social and economic factors and has resulted in an increase in the prevalence of chromosomal abnormalities. There is a rapid increase in the demand for developing advanced diagnostic procedures for early screening to detect genetic abnormalities resulted from the improper division of chromosomes, which is one of the major factors driving the growth of the Non-Invasive Prenatal Testing Market.

Non-Invasive Prenatal Testing Market Challenges 

High Cost of Non-Invasive Prenatal Testing

The key players are focusing on developing advanced screening technologies that are effective and accurate in the early detection of genetic disorders owing to the rising chromosomal abnormalities. However, the high cost of Non-Invasive Prenatal Testing is one of the major factors that is estimated to reduce the growth of the Non-Invasive Prenatal Testing Market.

Non-Invasive Prenatal Testing Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Non-Invasive Prenatal Testing Market. Key companies of this market are Agilent Technologies Inc, F Hoffman-La Roche Ltd, Illumina Inc, Koninklijke Philip N.V., Thermo Fisher Scientific Inc, Perkinelmer, Inc, Qiagen N.V., Natera Inc, Progenity Inc, and CooperSurgical Inc among others.

Partnerships/Product Launches:

  • In June 2020, Koninklijke Philip N.V. has launched noninvasive prenatal testing device, Fetal and Maternal Pod and Patch to allow for continuous monitoring of maternal heart rate and to provide multiple benefits to expectant mothers, such as mobility, and flexibility
  • In June 2019, Thermo Fisher Scientific has entered into a partnership with NX Prenatal to detect and manage pregnancy-related complications using novel non-invasive prenatal testing methods and to develop mass spectrometry (MS)-based proteomics assays for assessing the risk of adverse outcomes.
  • In April 2019, Progenity Inc has launched Resura, which is a custom-designed and noninvasive prenatal test for monogenic diseases to broaden parents’ prenatal testing options and to include a noninvasive test tailored to the family’s risk for a specific disease.

Relevant Reports:

For more Lifesciences and Healthcare Market reports, please click here
1. Non-Invasive Prenatal Testing Market - Overview
    1.1 Definitions and Scope
2. Non-Invasive Prenatal Testing Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Method
    2.4 Key trends by Geography
3. Non-Invasive Prenatal Testing Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Non-Invasive Prenatal Testing Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Non-Invasive Prenatal Testing Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Non-Invasive Prenatal Testing Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Non-Invasive Prenatal Testing Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Non-Invasive Prenatal Testing Market – By Product Type(Market Size –$Million/$Billion)
    8.1 Consumables
    8.2 Assay Kits and Reagents
    8.3 Disposables
    8.4 Instruments
    8.5 Microarrays
    8.6 Ultrasound Devices
    8.7 Others
9. Non-Invasive Prenatal Testing Market – By Method(Market Size –$Million/$Billion)
    9.1 Ultrasound Detection
    9.2 Biochemical Screening Test
    9.3 Cell-free DNA Screening in Maternal Plasma Test
    9.4 Fetal Cell in Maternal Blood Test
10. Non-Invasive Prenatal Testing Market – By Application(Market Size –$Million/$Billion)
    10.1 Trisomy
    10.2 Microdeletion Syndrome
    10.3 Others
11. Non-Invasive Prenatal Testing Market – By End User(Market Size –$Million/$Billion)
    11.1 Diagnostic Laboratories
    11.2 Hospitals
    11.3 Others
12. Non-Invasive Prenatal Testing Market - By Geography(Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Mexico
        12.1.3 Canada
    12.2 Europe
        12.2.1 U.K.
        12.2.2 France
        12.2.3 Germany
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia Pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Non-Invasive Prenatal Testing Market - Entropy
14. Non-Invasive Prenatal Testing Market – Industry/Segment Competition Landscape Premium
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Best Practices for Companies
15. Non-Invasive Prenatal Testing Market – Key Company List by Country Premium Premium
16. Non-Invasive Prenatal Testing Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competitive Landscape Market 2023-2030 ($M)
1.1 Market Participation Categorization Market 2023-2030 ($M) - Global Industry Research
2.Global Competitive Landscape Market 2023-2030 (Volume/Units)
2.1 Market Participation Categorization Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Competitive Landscape Market 2023-2030 ($M)
3.1 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
4.South America Competitive Landscape Market 2023-2030 ($M)
4.1 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
5.Europe Competitive Landscape Market 2023-2030 ($M)
5.1 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
6.APAC Competitive Landscape Market 2023-2030 ($M)
6.1 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
7.MENA Competitive Landscape Market 2023-2030 ($M)
7.1 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
2.Canada Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
3.Mexico Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
4.Brazil Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
5.Argentina Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
6.Peru Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
7.Colombia Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
8.Chile Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
9.Rest of South America Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
10.UK Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
11.Germany Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
12.France Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
13.Italy Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
14.Spain Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
15.Rest of Europe Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
16.China Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
17.India Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
18.Japan Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
19.South Korea Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
20.South Africa Non-Invasive Prenatal Testing Market Revenue, 2023-2030 ($M)
21.North America Non-Invasive Prenatal Testing By Application
22.South America Non-Invasive Prenatal Testing By Application
23.Europe Non-Invasive Prenatal Testing By Application
24.APAC Non-Invasive Prenatal Testing By Application
25.MENA Non-Invasive Prenatal Testing By Application